Michael Lilly
Overview
Explore the profile of Michael Lilly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
847
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Janneh A, Kassir M, Atilgan F, Lee H, Sheridan M, Oleinik N, et al.
Cell Rep
. 2022 Dec;
41(10):111742.
PMID: 36476873
Crosstalk between metabolic and signaling events that induce tumor metastasis remains elusive. Here, we determine how oncogenic sphingosine 1-phosphate (S1P) metabolism induces intracellular C3 complement activation to enhance migration/metastasis. We...
2.
Swami U, Zimmerman R, Nussenzveig R, Hernandez E, Jo Y, Sayegh N, et al.
Front Oncol
. 2022 Oct;
12:966534.
PMID: 36185208
-mutated prostate cancer has been shown to be less responsive to poly (ADP-ribose) polymerase (PARP) inhibitors as compared to -mutated prostate cancer. The reason for this differential response is not...
3.
Wang X, Zhou Z, Turner D, Lilly M, Ou T, Jiang W
J Immunol Res
. 2022 Feb;
2022:2574964.
PMID: 35155686
Backgrounds: Infection and inflammation play an important role in prostate cancer (PCa) etiology and pathogenesis. However, the environmental drivers for PCa are not fully understood. Methods: In a cross-sectional study,...
4.
Zhuang E, Uchio E, Lilly M, Zi X, Fruehauf J
Biomed Pharmacother
. 2021 Oct;
143:112226.
PMID: 34649352
We carried out a phase II study to investigate the activity of docetaxel plus lycopene in advanced castrate resistant adenocarcinoma of the prostate. Patients were chemotherapy and biological therapy naive....
5.
Knochelmann H, Rivera-Reyes A, Wyatt M, Smith A, Chamness R, Dwyer C, et al.
Oncoimmunology
. 2021 Aug;
10(1):1959101.
PMID: 34408920
Adoptive transfer of tumor-infiltrating lymphocytes (TIL) elicits the regression of metastatic malignancies, yet a low proportion of patients achieve complete durable responses. The high incidence of relapse in these patients...
6.
Halbert C, Jefferson M, Allen C, Babatunde O, Drake R, Angel P, et al.
JCO Clin Cancer Inform
. 2021 Jul;
5:768-774.
PMID: 34328797
Purpose: The purpose of this study was to examine racial differences in patient portal activation and research participation among patients with prostate cancer. Materials And Methods: Participants were African American...
7.
Rahmatpanah F, De Robles G, Lilly M, Keane T, Kumar V, Mercola D, et al.
Oncotarget
. 2021 Jul;
12(15):1457-1469.
PMID: 34316327
Prostate cancer (PCa) in Black Americans (BA) is diagnosed at an earlier median age and a more advanced stage than PCa in White Americans (WA). Tumor-adjacent stroma (TAS) plays a...
8.
Bauer A, Jefferson M, Nahhas G, Savage S, Drake R, Lilly M, et al.
Cancer Med
. 2020 Oct;
9(23):8765-8771.
PMID: 33070458
Purpose: To examine financial toxicity and strain among men in an equal access healthcare system based on social determinants and clinical characteristics. Methods: Observational study among men receiving prostate cancer...
9.
Halbert C, Jefferson M, Drake R, Lilly M, Savage S, Nahhas G, et al.
Support Care Cancer
. 2020 May;
29(1):459-465.
PMID: 32394247
Purpose: Physical activity is important for enhancing quality of life and cancer control among prostate cancer survivors. The purpose of this study was to characterize adherence to physical activity guidelines...
10.
Jefferson M, Drake R, Lilly M, Savage S, Price S, Halbert C
Ethn Dis
. 2020 Apr;
30(Suppl 1):185-192.
PMID: 32269460
Objective: To characterize rates of co-morbidity among prostate cancer patients treated with radical prostatectomy and to examine the association between co-morbidity status and race, clinical factors, and health behaviors for...